Sanara Medtech logo
SMTISanara Medtech
Trade SMTI now
Sanara Medtech primary media

About Sanara Medtech

Sanara Medtech (NASDAQ:SMTI), (OTCQB:SMTI) specializes in developing, marketing, and distributing wound and skin care products to physicians, hospitals, and clinics. Its portfolio includes innovative solutions aimed at improving patient outcomes and reducing healthcare costs in the areas of wound and skin care. The company is focused on bringing to market products that meet the highest standards for efficacy, safety, and patient care. Sanara Medtech's projects range from advanced wound care treatments to surgical wound management, all designed with the objective of addressing the complex needs of wound healing and skin integrity. The company aims to enhance patient healing and provide healthcare professionals with superior solutions for wound and skin care management.

What is SMTI known for?

Snapshot

Public US
Ownership
2001
Year founded
102
Employees
Fort Worth, United States
Head office
1 of 5
US Rank
Unknown
Sector
N/A
Sector rank
Loading Map...

Operations

All Locations
Fort Worth, US

Produtos e/ou serviços de Sanara Medtech

  • Wound and skincare products designed to promote healing and manage infections in both surgical and chronic wounds.
  • Surgical and wound care education programs for healthcare professionals to improve patient outcomes and care standards.
  • Post-surgical recovery kits tailored to reduce the risk of infection and promote faster healing times for patients.
  • Advanced telehealth services providing remote wound assessment and treatment recommendations, improving access to specialized wound care.

equipe executiva do Sanara Medtech

  • Mr. Ronald T. NixonExecutive Chairman
  • Mr. Jacob A. WaldropChief Operating Officer
  • Mr. Seth D. YonPresident, CEO & Director
  • Ms. Elizabeth B. TaylorChief Financial Officer
  • Ms. Ashley M. MackeyPrincipal Accounting Officer
  • Mr. Bill FitzgeraldChief Compliance Officer
  • Ms. Tricia MattesonVice President of Marketing
  • Mr. Tyler PalmerChief Corporate Development & Strategy Officer
  • Suresh V. MuppallaPresident & CEO of THP
  • Ms. Nina BiondaChief R&D Officer

Connect with us

Disclaimer

Grafa is not a financial advisor. You should seek independent, legal, financial, taxation or other advice that relate to your unique circumstances.

Grafa is not liable for any loss caused, whether due to negligence or otherwise arising from the use of or reliance on the information provided directly or indirectly, by use of this platform.